Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

35.69
+0.41001.16%
Post-market: 35.690.00000.00%19:10 EST
Volume:1.08M
Turnover:38.62M
Market Cap:3.80B
PE:43.52
High:36.06
Open:35.28
Low:34.93
Close:35.28
52wk High:117.33
52wk Low:28.66
Shares:106.37M
Float Shares:86.88M
Volume Ratio:0.64
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8200
EPS(LYR):0.8200
ROE:15.01%
ROA:3.34%
PB:5.86
PE(LYR):43.52

Loading ...

Corcept Therapeutics Down Over 48%, on Pace for Largest Percent Decrease Since May 2014 -- Data Talk

Dow Jones
·
Jan 01

Wolfe Research Downgrades Corcept Therapeutics to Underperform from Peer Perform, Price Target is $30

MT Newswires Live
·
Dec 31, 2025

US FDA Declines to Approve Corcept's Drug for Rare Hormonal Disorder

Reuters
·
Dec 31, 2025

Corcept Therapeutics (CORT.US) Plummets Over 46% Following FDA Rejection of New Drug Application

Stock News
·
Dec 31, 2025

These Stocks Are Moving the Most Today: Nvidia, Tesla, Hecla, Newmont, Nike, Vanda, Corcept, DJT, and More -- Barrons.com

Dow Jones
·
Dec 31, 2025

BUZZ-Corcept drops after US FDA declines to approve drug for rare hormonal disorder

Reuters
·
Dec 31, 2025

Corcept Therapeutics' Relacorilant Faces Setback as FDA Issues Complete Response Letter on Hypertension Treatment

MT Newswires Live
·
Dec 31, 2025

Shares of Corcept Therapeutics Fall 34.5% Premarket After US FDA Declines to Approve Co's Drug for Rare Hormonal Disorder

THOMSON REUTERS
·
Dec 31, 2025

BRIEF-Corcept Receives Complete Response Letter For Relacorilant As A Treatment For Patients With Hypercortisolism

Reuters
·
Dec 31, 2025

Corcept Therapeutics Inc - FDA Issues Complete Response Letter for Relacorilant Nda

THOMSON REUTERS
·
Dec 31, 2025

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM

Reuters
·
Dec 31, 2025

S&P 500 Futures Decline In Premarket Trading; Corcept Therapeutics, Hecla Mining Lag

Dow Jones
·
Dec 31, 2025

Insider Confidence In December 2025's Leading Growth Companies

Simply Wall St.
·
Dec 26, 2025

High Growth Companies With Strong Insider Confidence December 2025

Simply Wall St.
·
Dec 25, 2025

Corcept Therapeutics' Upcoming FDA Decision: Is A CRL Likely?

Benzinga_recent_news
·
Dec 23, 2025

Corcept Therapeutics (CORT): Assessing Valuation After a Strong Year-to-Date Share Price Surge

Simply Wall St.
·
Dec 22, 2025

These Stock Funds Are Cruising. Their 2026 Picks. -- Barron's

Dow Jones
·
Dec 20, 2025

These Stock Funds Are Crushing the Market. Here Are Their Picks for 2026. -- Barrons.com

Dow Jones
·
Dec 19, 2025

Corcept's Hypercortisolism Sales Outlook Seen as Unrealistic -- Market Talk

Dow Jones
·
Dec 17, 2025

Oil Prices Sink To $55, Lowest In Nearly 5 Years: What's Moving Markets Tuesday?

Benzinga
·
Dec 17, 2025